GFPC
EXAS

Global Financial Private Client’s Exact Sciences EXAS Stock Holding History

Global Financial Private Client’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8
Closed -$346 – 667
2025
Q1 		$346 Buy
8
+5
+167% +$253 ﹤0.01% 1404
2024
Q4 		$169 Buy
+3
New +$187 ﹤0.01% 1338

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Global Financial Private Client's EXAS Position: Q2 2025 in Review

Global Financial Private Client sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 8 shares — an estimated $346 sold.

Global Financial Private Client first reported a position in EXAS in Q4 2024 and held it in 2 quarters. The position peaked at $346 in Q1 2025. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Global Financial Private Client reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 8 Exact Sciences shares in Q2 2025, an estimated $346.
  • Global Financial Private Client first reported a position in Exact Sciences in Q4 2024 and held it in 2 quarters.
  • Global Financial Private Client's Exact Sciences position peaked at $346 in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.